financing

News

BiVictriX's chief executive Tiffany Thorn

Another AIM defection as BiVictriX plans to delist

The list of UK biotechs deciding to abandon listings on the AIM exchange in the UK just lengthened, after BiVictriX said it wants to cancel its shares and go private.

News

Biopharma, finance vets launch $600m life sciences loan firm

There's a new source of funding for life sciences companies in town, providing credit as an alternative to other financing avenues such as venture capital.

News

Oxford Nanopore rises on Novo Holdings equity stake

Shares in genomics sequencing company Oxford Nanopore were rising sharply this morning after it announced an £80 million ($102 million) share placement that included a £50 million investmen

News

Third Arc's $165m for T cell engagers, plus other bio rounds

This week's round-up of new financings in the biotech world is headed by a big round for Third Arc, a specialist in T-cell engager antibodies, with Autobahn, Brenig, Confo, and GRO Bio also

News

Cardurion heads crop of sizeable bio financings

While the pace of biotech private rounds seems to have slowed a little of late, this week saw four big financings for Cardurion Pharma, Scorpion Therapeutics, CatalYm, and NGM Bio.

News

Huma raises $80m, launches 'Shopify for digital health'

Huma has raised $80 million in fourth-round financing that will go in part towards rolling out a new platform that can be used by developers to create disease management tools.

Another AIM defection as BiVictriX plans to delist

Biopharma, finance vets launch $600m life sciences loan firm

Oxford Nanopore rises on Novo Holdings equity stake

Third Arc's $165m for T cell engagers, plus other bio rounds

Cardurion heads crop of sizeable bio financings

Huma raises $80m, launches 'Shopify for digital health'

Lilly's 'triple G' retatrutide aces crucial obesity trial

Discover a new era of healthcare panel engagement: Grounded ...

financing

Editor's Picks